Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

FDA Schedules Third Orphan Drug Workshop for Nov. 4-5, 2010

October 13, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Oct. 13 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration has scheduled the third in a series of workshops on orphan drug designation for academics, biotechnology companies, and those unfamiliar with the process for Nov. 4-5, 2010, in Lansdowne, Va....

TOPICS:

Bisphosphonates (Osteoporosis Drugs): Label Change - Atypical Fractures Update

October 13, 2010 9:30 am | by U.S. Food & Drug Administration | News | Comments

Risk of atypical fractures of the thigh, known as subtrochanteric and diaphyseal femur fractures, in patients who take bisphosphonates for osteoporosis.

TOPICS:

Cantel 4Q profit rises 8 percent on sales

October 13, 2010 8:45 am | by The Associated Press | News | Comments

Cantel Medical Corp., which makes products used to prevent infections, said Wednesday its fiscal fourth-quarter profit rose 8 percent as sales grew in the company's endoscope reprocessing and water purification divisions.Cantel said its net income rose to $4.6 million, or 27 cents per share, in...

Advertisement

FDA approves Alkermes' opioid dependence treatment

October 13, 2010 8:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Alkermes' once-monthly medication Vivitrol has won approval by the U.S. Food and Drug Administration as a non-narcotic, non-addictive treatment for opioid dependence.

New Study Says Sustainability is Key for the Future Success of the Logistics Industry

October 13, 2010 8:34 am | by Material Handling Industry of America | News | Comments

The pursuit of sustainability will transform the logistics industry, both in terms of its business model as well as the range of advanced solutions and technologies that will be used by logistics service providers. This is one conclusion drawn by a recent

LaunchCapital, CI invest $1.3M in Affinimark

October 13, 2010 6:33 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Affinimark Technologies Inc., a New Haven, Conn., company that develops point-of-care tests for cerebrospinal leaks has received a $1,359,394 investment by the quasi-public agency Connecticut Innovations and LaunchCapital.

TOPICS:

Cardium Announces New Research Findings: Excellagen Product Candidate Activates Platelet Release of PDGF, an Important Growth Factor Fundamental to the Wound Healing Process

October 13, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Oct. 13 /- Cardium Therapeutics (NYSE Amex: CXM ) today reported on new preclinical research findings that Excellagen, a topically applied formulated collagen wound management gel product candidate, activates platelet release of platelet-derived growth factor (PDGF) locally at...

TOPICS:

Hologic to Host Investor Presentation at RSNA 2010

October 13, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Mass., Oct. 13 /- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced the Company will host...

TOPICS:
Advertisement

Accuray Incorporated to Host Analyst Meeting at ASTRO 2010

October 13, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Oct. 13 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, will host an Analyst Meeting in San Diego, Calif., on Monday, November 1, 2010 at 3:30 p.m. PT/ 6:30 p.m. ET. This meeting coincides with the 52nd Annual Meeting of the...

TOPICS:

Highland Capital Management Announces 100% Ownership of American HomePatient, Completes Successful Public to Private Transition For Leading Provider of Home Respiratory Therap...

October 13, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

DALLAS, Oct. 13 /- Highland Capital Management, L.P. ("Highland"), a Dallas-based, SEC-registered investment adviser with approximately $22 billion of assets under management, announced today that American HomePatient, Inc. ("American HomePatient" or "the Company") --  which...

TOPICS:

Waismann Method Extends Aid in an Effort to Make Treatment More Widely Available

October 13, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

BEVERLY HILLS, Calif., Oct. 13 /- In support of recent and upcoming national drug take-back programs encouraging people to surrender unused, unwanted and expired medications, the medical professionals who perform the Waismann Method of Opiate Detoxification today announced they will...

TOPICS:

Federal Register: Innovations in Technology for the Treatment of Diabetes: Clinical Development of the Artificial Pancreas (an Autonomous System); Public Workshop

October 13, 2010 6:30 am | by U.S. Food & Drug Administration | News | Comments

The topics to be discussed are the current state of device systems for autonomous systems for the treatment of diabetes mellitus, the challenges in developing this expert system using existing technology, a discussion of the clinical expectations and...

TOPICS:

"SpectroPen" Could Aid Surgeons in Detecting Edges of Tumors

October 13, 2010 5:32 am | by Georgia Tech Institute of Technology | News | Comments

Biomedical engineers are developing a hand-held device called a SpectroPen that could help surgeons see the edges of tumors in human patients in real time during surgery.

TOPICS:

Biomet 1Q sales disappoint, rising 2 percent

October 13, 2010 4:45 am | by The Associated Press | News | Comments

Medical device maker Biomet Inc. said Wednesday its sales rose 2 percent in the first quarter, slower than the privately held company had expected.Biomet's quarterly results are considered an indicator on the state of the orthopedic device industry because it reports results before most of its...

Boston Scientific Announces Global Launch of Journey™ Guidewire

October 13, 2010 4:31 am | by Boston Scientific | News | Comments

Major advance in guidewire technology for challenging peripheral interventions

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading